$AB

AB Announces September 30, 2026 Assets Under Management

AllianceBernstein (NYSE: AB) reported a 2% decrease in assets under management to $900 billion in September 2026, driven by market depreciation and net outflows. Institutional channels saw inflows, offset by outflows in Retail and Private Wealth. Quarterly net inflows totaled $6.0 billion. The company issued forward-looking statements with typical cautionary language.

Original reporting
Published Oct 12, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AB
Bearish
medium confidence
Mentioned
$AB
Relevance
7/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$ABBearishLow
01

Why it matters

The disclosed AUM decline may trigger analyst revisions and short‑term price volatility.

02

Market read

First‑time disclosure of a material AUM reduction for a $900 billion manager; modest trading relevance.

03

What to watch

Potential upcoming product launches or fee‑rate adjustments are not disclosed and could offset the AUM decline.

Relevance 7/10Novelty 7/10Timing: released today

Background

AllianceBernstein is a major global investment manager; its AUM figures are a key metric for performance assessment.

Company-level read

Ticker impact

$ABBearishMedium confidence
Context

AllianceBernstein disclosed its preliminary assets under management fell to $900 billion in September 2026, a 2% decline from the prior month.

Expected impact

likely downward pressure as the market prices in weaker asset growth

Evidence & confidence

A 2% month‑over‑month AUM drop signals slower inflows and market depreciation, which historically correlates with short‑term share price weakness for asset managers.

Market effects

May signal broader pressure on the asset‑management sector if market depreciation persists.

US‑listed asset managers could see modest sell‑offs.

Limited to investors tracking large global managers.

Counterpoint

The AUM dip could be a temporary market‑wide effect; long‑term investors might view the outflows as a buying opportunity.

Key entities

  • AllianceBernstein

    Global investment management firm reporting AUM decline.

Related articles

$ABMed

People moves: AllianceBernstein names Onur Erzan as next CEO

AllianceBernstein (AB) named Onur Erzan as its next CEO, effective April 1, 2027. Erzan, currently president, succeeds Seth Bernstein, who retires but remains on AB's board. AB's assets under management are $919 billion, with $169 billion in private wealth. Erzan joined AB in 2021 from McKinsey and has led key initiatives. AB is a subsidiary of Equitable Holdings.

$ABMedAI 8/10

AB Science raises EUR 14.2m to fund masitinib Phase III, AB8939

AB Science (Euronext Paris: AB) raised EUR 14.2m via a private placement to fund early steps of a strategic plan due in September. The issue created 23.28m new shares; an existing long-term investor provided EUR 12m. Proceeds target AB8939 in AML and masitinib Phase III in ALS. Cash is about EUR 23m, covering needs beyond 12 months.

$ABMed

AllianceBernstein Holding L.P. Q2 2026 Earnings Call Summary

Strategic Execution and Platform Scaling Achieved record AUM of $905 billion, driven by a return to positive organic growth and the strongest gross sales quarter in five years. Reached the $90 billion to $100 billion private markets AUM target more than a year ahead of schedule, validating a multi-year investment strategy in corporate lending and real estate debt.

$ABMed

AllianceBernstein Holding LP (AB) Q2 2026 Earnings Call Highlights: Record AUM

AllianceBernstein (AB) discussed Q2 2026 earnings call topics, including expectations for the Equitable Corebridge merger to add about $100B of AUM over a couple of years, with combined general account assets around $350B and separate around $200B. Management cited resilient private wealth adviser productivity, reduced expense guidance by $5-10M, and demand shifts in U.S. taxable fixed income.

$ABMedAI 8/10

Advanced Bionics Receives FDA Approval for Expanded Cochlear Implant Candidacy Criteria in SSD and AHL

Advanced Bionics, a Sonova brand, said the US FDA approved expanded indications for its cochlear implant systems for single-sided deafness (SSD) and asymmetric hearing loss (AHL). The criteria broaden adult and pediatric eligibility, with company-cited research estimating 271,000 to 345,000 US adults with SSD and only 2.1% using CIs among eligible patients.

$ABMed

ALLIANCEBERNSTEIN HOLDING L.P. ANNOUNCES SECOND QUARTER RESULTS

ALLIANCEBERNSTEIN HOLDING L.P. (AB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.01 2 a2q26earningsrelease.htm EX-99.01 2Q26 RELEASE Document Ioanis Jorgali, Investors 629.213.6139 ioanis.jorgali@alliancebernstein.com Carly Symington, Media 629.213.5568 carly.symington@alliancebernstein.com ALLIANCEBERNSTEIN HOLDING L.P. ANNOUNCES SECOND QUARTER RESULTS